BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Y, Huang ZX, Song B. Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma. World J Gastroenterol 2021; 27(22): 3037-3049 [PMID: 34168406 DOI: 10.3748/wjg.v27.i22.3037]
URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3037.htm
Number Citing Articles
Victor Hugo Fonseca de Jesus, Rachel P. Riechelmann. Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s PerspectiveCancer Control 2023; 30: 107327482311732 doi: 10.1177/10732748231173212
Madeline T. Olson, Eric N. Aguilar, Cory L. Brooks, Carly C. Isder, Kathryn M. Muilenburg, Geoffrey A. Talmon, Quan P. Ly, Mark A. Carlson, Michael A. Hollingsworth, Aaron M. Mohs. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic CancerMolecular Pharmaceutics 2022; 19(10): 3586 doi: 10.1021/acs.molpharmaceut.2c00203
Tomoyuki Kawada. Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomyJournal of Surgical Oncology 2022; 125(6): 1071 doi: 10.1002/jso.26819
Luis Secanella, Juli Busquets, Núria Peláez, María Sorribas, Berta Laquente, Sandra Ruiz, Thiago Carnaval, Sebastián Videla, Juan Fabregat. Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort studyMedicine 2022; 101(48): e32126 doi: 10.1097/MD.0000000000032126
Chao Qu, Piao‐e Zeng, Hang‐yan Wang, Chun‐hui Yuan, Hui‐shu Yuan, Dian‐rong Xiu. Application of Magnetic Resonance Imaging in Neoadjuvant Treatment of Pancreatic Ductal AdenocarcinomaJournal of Magnetic Resonance Imaging 2022; 55(6): 1625 doi: 10.1002/jmri.28096
Yun Bian, Hui Jiang, Jianming Zheng, Chengwei Shao, Jianping Lu. Basic pancreatic lesions: Radiologic-pathologic correlationJournal of Translational Internal Medicine 2022; 10(1): 18 doi: 10.2478/jtim-2022-0003
Wenke Yin, Xiaoyan Song, Yue Xiang. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4Open Medicine 2023; 18(1) doi: 10.1515/med-2022-0624
Amanda Puleo, Midhun Malla, Brian A. Boone. Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal AdenocarcinomaPancreas 2022; 51(9): 1083 doi: 10.1097/MPA.0000000000002147